Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/08/2010EP2258360A2 Method for the treatment or prevention of lower urinary tract symptoms
12/08/2010EP2258359A2 Neurogenesis by muscarinic receptor modulation with sabcomelin
12/08/2010EP2258358A2 Neurogenesis with acetylcholinesterase inhibitor
12/08/2010EP2258357A2 Neurogenesis with acetylcholinesterase inhibitor
12/08/2010EP2258356A2 Chemical compounds having antiviral activity against dengue virus and other flaviviruses
12/08/2010EP2258354A1 Compounds and methods for controlling alcohol intake
12/08/2010EP2258353A2 Dosage form containing oxycodone and naloxone
12/08/2010EP2258352A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
12/08/2010EP2258351A2 Granules containing lansoprazole in large amount
12/08/2010EP2258350A2 Taste masked dosage form containing roflumilast
12/08/2010EP2258349A2 Swellable dosage form comprising gellan gum
12/08/2010EP2258348A2 Method for preparing microparticles having a selected polymer molecular weight
12/08/2010EP2258347A2 Tamper-resistant products for opioid delivery
12/08/2010EP2258346A2 Solid pharmaceutical dosage form comprising an HIV protease inhibitor solid dispersion
12/08/2010EP2258345A2 Solid pharmaceutical dosage form comprising an HIV protease inhibitor solid dispersion
12/08/2010EP2258344A2 Solid pharmaceutical dosage form comprising a ritonavir and lopinavir solid dispersion
12/08/2010EP2258341A2 Gastric acid secretion inhibiting composition
12/08/2010EP2258219A1 Nutrition with lipids and non-digestible saccharides
12/08/2010EP2258207A1 Pasteurisation process for microbial cells and microbial oil
12/08/2010EP2258183A1 Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs
12/08/2010EP2258166A1 Method for producing founder animal for reproducing animals having lethal phenotype caused by gene modification
12/08/2010EP2257626A2 Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
12/08/2010EP2257568A1 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use
12/08/2010EP2257567A1 Novel 17 beta lupane derivatives
12/08/2010EP2257558A1 Copper organocomplexes, use thereof as antitumor means and for protecting healthy tissue from ionizing radiation
12/08/2010EP2257556A1 Prasugrel salts with improved properties
12/08/2010EP2257555A1 Thieno[2,3-d]-pyrimidine-4(3h)-one compounds with antifungal properties and process thereof
12/08/2010EP2257554A1 Tricyclic benzoý4,5¨thieno-ý2,3-d¨pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use
12/08/2010EP2257553A1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
12/08/2010EP2257552A1 Heterocyclic compounds as inhibitors of cxcr2
12/08/2010EP2257551A2 Azatricyclic antibiotic compounds
12/08/2010EP2257550A1 Novel 1,4-diaza-bicycloý3.2.2¨nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors
12/08/2010EP2257549A1 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloal kanes
12/08/2010EP2257548A1 Therapeutic compounds
12/08/2010EP2257547A1 Novel benzimidazole linked pyrroloý2,1-qý1,4¨benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
12/08/2010EP2257546A2 Functionally selective alpha2c adrenoreceptor agonists
12/08/2010EP2257545A1 Pyrrolidinyl derivatives and uses thereof
12/08/2010EP2257544A2 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
12/08/2010EP2257543A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177
12/08/2010EP2257542A1 Gamma secretase modulators for the treatment of alzheimer ' s disease
12/08/2010EP2257541A1 Modulators for amyloid beta
12/08/2010EP2257539A1 Substituted 4-hydroxypyrimidine-5-carboxamides
12/08/2010EP2257535A1 Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators
12/08/2010EP2257534A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257533A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257531A1 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors
12/08/2010EP2257529A2 Pyridines and pyrazines as inhibitors of pi3k
12/08/2010EP2257528A2 1 ibeta-hydroxysteroid dehydrogenase inhibitors
12/08/2010EP2257527A1 Substituted sulfonamide derivatives
12/08/2010EP2257526A1 Spiro(5.5)undecane derivatives
12/08/2010EP2257517A1 Salts of memantine and cox-inhibitors and their crystal form in the treatment of pain
12/08/2010EP2257515A1 1,4-naphthoquinone derivatives and therapeutic use thereof
12/08/2010EP2257340A2 Compounds for treating muscular dystrophy
12/08/2010EP2257313A2 Ultra-small rnas as toll-like receptor-3 antagonists
12/08/2010EP2257300A2 Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
12/08/2010EP2257299A1 Modulation of srpx2-mediated angiogenesis
12/08/2010EP2257298A2 Genetic polymorphisms associated with stroke, methods of detection and uses thereof
12/08/2010EP2257297A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
12/08/2010EP2257296A1 Poly aromatic sodium channel blockers
12/08/2010EP2257295A1 Photodynamic therapy process and photosensitizer compositions
12/08/2010EP2257294A2 Treatment of herpes virus related diseases
12/08/2010EP2257293A2 Combination therapy with c-met and egfr antagonists
12/08/2010EP2257292A2 Zn/trimethoprim combination therapy
12/08/2010EP2257291A2 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
12/08/2010EP2257290A1 Kit, composition, product or medicament for treating cognitive impairment
12/08/2010EP2257289A1 Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
12/08/2010EP2257288A1 Valsartan solid oral dosage forms and methods of making such formulations
12/08/2010EP2257287A2 Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates
12/08/2010EP2257286A1 Treatment of energy utilization disease
12/08/2010EP2257285A1 Combination anti-cancer agents
12/08/2010EP2257284A2 Methods of treating skin with aromatic skin-active ingredients
12/08/2010EP2257283A1 L-citrulline for treating endothelial dysfunction and erectile dysfunction
12/08/2010EP2257282A2 Fatty acid derivatives for use in the prevention and treatment of hsmi
12/08/2010EP2257281A2 Combination comprising a cannabinoid receptor binding compound and an opioid
12/08/2010EP2257278A1 Oral tablet compositions containing nateglinide and surfactan ph adjusting agent
12/08/2010EP2257277A1 Solubilisation method
12/08/2010EP2257275A2 Ketorolac tromethamine compositions for treating or preventing ocular pain
12/08/2010EP2257274A2 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
12/08/2010EP2257190A1 Mixed aqueous solution of l-lysine and l-threonine
12/08/2010EP2257187A1 Antimicrobial agents for the treatment of campylobacter species in the crop of a bird
12/08/2010EP2257185A1 Methods and compositions of sphingolipid for preventing and treating microbial infections
12/08/2010EP2257173A1 Methods of treating cardiovascular disorders associated with atherosclerosis
12/08/2010EP2257172A2 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
12/08/2010EP2257171A1 Tetrahydro-1h-pyrrolo fused pyridones
12/08/2010EP2257170A1 Tetrahydrofuropyridones
12/08/2010EP2257169A1 Tetrahydrothieno pyridines
12/08/2010EP2257167A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
12/08/2010EP2257162A2 Crystal forms of 2-{2-ý(cyclohexyl)methylene¨hydrazino}adenosine
12/08/2010EP2257160A1 Diamide inhibitors of cytochrome p450
12/08/2010EP2038294B1 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same
12/08/2010EP1996584B1 Tropane prodrugs with central nervous system activity
12/08/2010EP1937257B1 Novel antibiotics comprising bis(1-aryl-5-tetraz0lyl)methane derivatives
12/08/2010EP1933835B1 Tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides as lfa-1 inhibitors
12/08/2010EP1904032B1 Fentanyl formulation containing an essential oil
12/08/2010EP1891011B1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
12/08/2010EP1884237B1 Amidino derivatives for use in the prevention or treatment of glaucoma
12/08/2010EP1858857B1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
12/08/2010EP1857108B1 Preventive or therapeutic agent for herpesvirus-related disease
12/08/2010EP1853254B1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
12/08/2010EP1848684B1 Ester-linked gemini surfactant compounds for use in gene therapy
1 ... 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 ... 7860